| Name | {[8-Chloro-3-(4-chlorobenzyl)-4-(difluoromethoxy)-2-ethyl-5-quinolinyl]oxy}acetic acid |
|---|---|
| Synonyms |
{[8-Chloro-3-(4-chlorobenzyl)-4-(difluoromethoxy)-2-ethyl-5-quinolinyl]oxy}acetic acid
Acetic acid, 2-[[8-chloro-3-[(4-chlorophenyl)methyl]-4-(difluoromethoxy)-2-ethyl-5-quinolinyl]oxy]- |
| Description | Pexopiprant is an oral antagonist of the prostaglandin D2 receptor 2 (DP2),Ki < 100nM. Pexopiprant can be used in studies of asthma[1]. |
|---|---|
| Related Catalog | |
| Target |
hDP2:<100 nM (Ki) |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 539.5±45.0 °C at 760 mmHg |
| Molecular Formula | C21H17Cl2F2NO4 |
| Molecular Weight | 456.27 |
| Flash Point | 280.1±28.7 °C |
| Exact Mass | 455.050262 |
| LogP | 6.04 |
| Vapour Pressure | 0.0±1.5 mmHg at 25°C |
| Index of Refraction | 1.601 |